125 results on '"Duell, Thomas"'
Search Results
2. Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study
3. Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
4. Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
5. Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
6. Immuntherapie des nichtkleinzelligen Lungenkarzinoms
7. Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients
8. Supplementary Data from Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial
9. Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
10. Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
11. Diagnostik und Therapie des kleinzelligen Lungenkarzinoms
12. Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
13. Treatment patterns and prognosis in inoperable stage III NSCLC after concurrent chemoradiotherapy with or without immune checkpoint inhibition: Historical overview.
14. NSCLC und SCLC*
15. Immuntherapie de nichtkleinzelligen Lungenkarzinoms
16. Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
17. Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer
18. Tödliches Erbe aus der industriellen Vergangenheit: Maligne asbestbedingte Lungen- und Pleuratumoren
19. Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting
20. Immuntherapie des nichtkleinzelligen Lungenkarzinoms
21. Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial
22. Die Nachsorge des Lungenkarzinoms
23. Die Nachsorge des Lungenkarzinoms
24. Erlotinib in Patients with Previously Irradiated, Recurrent Brain Metastases from Non-Small Cell Lung Cancer: Two Case Reports
25. Not the presence but the amount of clonal DNA detectable in remission of acute myeloid leukemia is predictive for relapse
26. Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation
27. VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials
28. Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma
29. Health and Functional Status of Long-Term Survivors of Bone Marrow Transplantation
30. Delineating Rearrangements in Single Yeast Artificial Chromosomes by Quantitative DNA Fiber Mapping
31. Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
32. Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
33. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
34. Die Nachsorge des Lungenkarzinoms.
35. Zielgerichtete und immunologische Therapie beim NSCLC
36. Genetic changes of non-small cell lung cancer under neoadjuvant therapy
37. Treatment of newly developed metastases after definitive chemoradiotherapy +/- ICI for unresectable stage III NSCLC.
38. Treatment of Isolated Intracranial Progression of Lung Cancer During Treatment with Systemic Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs)
39. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
40. Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer.
41. Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer.
42. EWSR 1-FUSION-NEGATIVE, SMARCB1-DEFICIENT PRIMARY PULMONARY MYXOID SARCOMA.
43. Tödliches Erbe aus der industriellen Vergangenheit
44. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
45. P3-155: De–novo–induction of lasting cranial remission in previously irradiated and pretreated patients with metastatic non–small–cell lung cancer
46. Clonal Karyotype Evolution Involving Ring Chromosome 1 with Myelodysplastic Syndrome Subtype RAEB-t Progressing into Acute Leukemia
47. Apolipoprotein B Gene Expression in a Series of Human Apolipoprotein B Transgenic Mice Generated withrecA-assisted Restriction Endonuclease Cleavage-modified Bacterial Artificial Chromosomes
48. Development of myeloma and secondary myelodysplastic syndrome from a common clone
49. High-Resolution Physical Map of the Immunoglobulin λ Variant Gene Cluster Assembled by Quantitative DNA Fiber Mapping
50. A Transcript Map Encompassing the Multiple Endocrine Neoplasia Type-1 (MEN1) Locus on Chromosome 11q13
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.